Leaning Into RWE:
The IRA is Here, So Now’s the Time
by Mike Munsell, PhD, Director of Research, Panalgo,
and Meg Richards, PhD, MPH
Executive Director of Solutions, Panalgo
Blogs
Check out Panalgo blogs to see our experts' takes on important topics in the healthcare analytics industry.
Leaning Into RWE:
Conclusions from Copenhagen: Highlights of ISPOR EU 2023
By Meg Richards, PhD, MPH Executive Director of Solutions, Panalgo
How RWE Improves Evidence Generation Across the Product Life Cycle
by Meg Richards, PhD, MPH
Executive Director of Solutions, Panalgo
Linking Real-World Data is Like Making a Fine, Blended Wine
by Meg Richards, PhD, MPH
Executive Director of Solutions, Panalgo
Highlights from Halifax: Six Themes from ICPE 2023
by Meg Richards, PhD, MPH
Executive Director of Solutions, Panalgo
How Machine Learning is Improving Patient Outcomes: 5 Use Cases in 5 Minutes
by Mike Munsell, PhD
Director of Research, Panalgo
Emerging Topics in Real-World Evidence: Part 2
A Q&A with Dr. Samy Suissa
Emerging Topics in Real-World Evidence: Part 1
A Q&A with Dr. Peter Neumann, ScD
From Our Point of View: Highlights of DIA 2023
DIA 2023 was in Panalgo’s hometown of Boston last week and as usual, it did not disappoint. This year’s theme was ‘Illuminate’ – shining a light on many important topics such as diversity in clinical studies, artificial intelligence (AI), and personalized or precision medicine. Some newer concepts surfaced as well, including a provocative discussion of […]
How Life Sciences is Leveraging Machine Learning: 5 Use Cases in 5 Minutes
By Mike Munsell, PhD
Insights & Innovators: Is Lab Data the Secret Weapon for More Efficient Clinical Trials?
By Ritupriya Yamujala
Insights & Innovators: Using Machine Learning to Develop Disease Predictability Models
Q&A with Chao Li, PhD
Insights & Innovators: A Q&A with Greg Norman and Poorva Nemlekar from Dexcom
Q&A with Greg Norman and Poorva Nemlekar from Dexcom
Insights & Innovators: A Q&A with Greg Norman and Katia Hannah from Dexcom
Q&A with Greg Norman and Katia Hannah from Dexcom
Building a Real-World Evidence Center of Excellence: Lessons from the Frontlines
Q&A with Margaret McDonald, Head of Apex Data Consulting, LLC, following a 17+ year career at Pfizer.
Leveraging RWD in Observational Studies: Understanding the Implications of Time-Related Biases
Q&A with Samy Suissa, PhD
Innovating RWE Organizations: Learning from the Past and Looking to the Future
Q&A with Christopher Boone, PhD, FACHE, FHIMMS
Pharma Commercial Teams: Building an Analytics Culture as a Driver of Competitive Advantage
By David Kreutter, PhD
Viewpoint: Life Sciences Should View Commercial Analytics Teams as a Revenue Generator
Q&A with Vijay Raghavan, Associate Vice President, Market Analytics and Business Insights, AbbVie
Interview with Dr. Mark Friedman on Covid-19 Complications and the Use of Real-World Data
Q&A with Dr. Mark Friedman
You Can Influence ICER Recommendations, You Just Need the Right Evidence
By Matthew Sussman, MA
BHE is Now Panalgo: Why We Changed Our Name and Brand
By Joe Menzin, PhD
ICER’s Development and Use of RWE: 5 Areas for Concern
By Matthew Sussman, MA
Five Ways to Use Early-Stage Models to Support Your Drug’s Value Proposition
By Jennifer Benner
ICER Versus NICE: Who Cares About Value-Based Pricing Assessments?
By Matthew Sussman, MA
Do Fixed Cost-Effectiveness Thresholds or CE Threshold Magnitudes Matter?
By Matthew Sussman, MA
How Does ICER’s Incremental Cost-Effectiveness Analysis Stack Up to Industry Practice?
By Matthew Sussman, MA
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization
